Swiss Biotech Windward Raises $225 Million in US IPO, Placement

Windward Bio Group AG, raised about $225 million in a US initial public offering that priced at the midpoint of its marketed range, along with a private placement.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.